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Objectives This study was designed to assess the prevalence of provoked exercise desaturation
(PED) in patients with patent foramen ovale (PFO) referred for cardiovascular evaluation and to eval-
uate the impact of PFO closure.
Background Platypnea orthodeoxia syndrome is a rare, mechanistically obscure consequence of
PFO that results in oxygen desaturation during postural changes. In our clinical experience, how-
ever, it is far less common than desaturation during exercise.
Methods This was a single-center prospective study of 50 patients with newly diagnosed PFO. Each
patient underwent standardized assessment for arterial oxygen saturation with pulse oximetry dur-
ing postural changes and stair climbing exercise. Provoked exercise desaturation was deﬁned as a
desaturation of at least 8% from baseline to 90%. All patients who underwent closure were re-
valuated 3 months after the procedure. Those with baseline PED were similarly reassessed for desatura-
ion at follow-up.
esults Mean age of the cohort was 46  17 years, 74% were female, 30% had migraines, and
8% had experienced a cerebrovascular event. Seventeen patients (34%) demonstrated PED. Pro-
oked exercise desaturation patients seemed demographically similar to non-PED patients. Ten PED
atients underwent PFO closure (2 surgical, and 8 percutaneous). Drop in oxygen saturation was
mproved by an average of 10.1  4.2% after closure (p  0.001), and New York Heart Association
functional class improved by a median of 1.5 classes (interquartile range: 0.75 to 2.00, p  0.008).
Conclusions One-third of patients referred for assessment of PFO experience oxygen desaturation
during stair exercise. Closure of PFO seems to ameliorate this phenomenon and improve functional
status. (J Am Coll Cardiol Intv 2012;5:416–9) © 2012 by the American College of Cardiology
Foundation
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417Platypnea orthodeoxia syndrome (POS) is traditionally
defined as dyspnea or hypoxemia observed when moving
from a recumbent to an upright or seated position (1,2).
lthough there are several potential causes for this phenom-
non, POS is classically described as resulting from right-
o-left shunting through a patent foramen ovale (PFO)
3,4). The precise mechanism of shunting through a PFO
espite normal intracardiac pressures, however, remains
bscure (5). Under physiological conditions the left atrial
ressure is typically 5 to 8 mm Hg higher than the right
trial pressure (6). Logically this pressure gradient should
See page 420
prevent right-to-left shunting and would thereby pre-
clude the mixing of deoxygenated blood with the sys-
temic circulation in the presence of a PFO. However,
specific circumstances, such as rigorous exertion might
sufficiently increase venous return to briefly overcome the
pressure difference, thereby initiating a transient shunt
(5). Certainly this so-called “provoked exercise desatura-
tion” (PED) would allow for right-to-left shunting in a
manner similar to but technically distinct from POS.
This mechanism of desaturation would agree with the
findings that: 1) desaturations caused by PFO can reflect
an inducible arterial desaturation and not a permanent
shunt (7); and 2) these desaturations are a rarely observed
phenomenon (1), even though PFO is present in up to
25% of the population (8).
In addition to the ambiguities surrounding the definition
nd mechanism of shunting through a PFO, the question of
ow to manage this enigmatic finding remains. Although
any patients undergo closure of PFO for oxygen desatu-
ation or dyspnea (9), the utility of this intervention has
ever been evaluated in a prospective manner. Furthermore,
ecently presented data from the CLOSURE I trial (A
rospective, Multicenter, Randomized, Controlled Trial to
valuate the Safety and Efficacy of the STARFlex Septal
losure System vs. Best Medical Therapy in Patients with
troke or Transient Ischemic Attack due to Presumed
aradoxical Embolism through a Patent Foramen Ovale)
10) have given more weight to conservative management
ver intervention when weighing the potential risks and
enefits of PFO closure. In light of these complexities, we
ought to examine the prevalence of PED in a population of
atients referred for cardiovascular recommendations with
egard to PFO management and investigate the impact of
FO closure on those patients exhibiting PED.
ethods
A diverse cohort of consecutive patients undergoing con-
sultation for newly diagnosed PFO in an adult congenital
heart clinic was prospectively enrolled between August 2009and December 2010. The diagnosis of PFO was confirmed
in each patient by transthoracic and/or transesophageal
echocardiogram with agitated saline contrast and color
Doppler imaging. As part of their initial workup each
patient underwent standardized assessment of their arterial
oxygen saturation. Saturations were measured with an
OxiMax pulse oximeter (Nellcor OxiMax, Pleasanton, Cal-
ifornia), in a seated position, standing, while ambulating,
and during ascent and decent of 4 flights of stairs. We
defined PED as those patients experiencing a sustained
arterial desaturation during assessment of at least 8% to a
value 90%. The decision to undergo PFO closure was not
controlled by the study protocol and was left to the
discretion of both the clinician and the patient.
All patients who underwent percutaneous PFO closure
were re-evaluated in the office 3 months after the procedure.
Persistence of an atrial level shunt was assessed by trans-
thoracic echocardiography with agitated saline contrast and
color Doppler at that time. Patients who demonstrated
PED during original assessment were re-evaluated for
arterial desaturation during exercise with the same tech-
nique used during initial assess-
ment. New York Heart Associ-
ation (NYHA) functional class
was assessed and recorded at
each visit with a very detailed
review of systems.
Data are presented as mean 
SD for continuous variables and
as a percentage for discrete vari-
ables. Comparison of dichoto-
mous variables was performed
with the Pearson chi-square test
or Fisher exact test where appropriate. Comparisons of
continuous variables between groups were performed with
2-sided t tests. Comparisons of individual patient outcomes
before and after PFO closure were performed with matched
pair analysis with Wilcoxon matched-pairs signed-ranks test
or paired t test where appropriate. For all tests a p value
0.05 was considered statistically significant. Data were
analyzed and compiled with JMP 9.0 software (SAS Insti-
tute, Inc., Cary, North Carolina).
Results
During the 17-month period a total of 50 patients with
PFO were enrolled into the study. The baseline demo-
graphic data of our cohort are listed in Table 1: 34% of
patients had an atrial septal aneurysm, 30% had experienced
migraine headaches, and 48% had suffered a transient
ischemic attack or stroke with confirmatory imaging.
Twenty-two patients (44%) were referred specifically due to
concern for paradoxical embolism, 6 patients (12%) were
Abbreviations
and Acronyms
NYHA  New York Heart
Association
PED  provoked exercise
desaturation
PFO  patent foramen ovale
POS  platypnea
orthodeoxia syndromereferred for POS, and 22 (44%) were referred for evaluation
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418of an incidentally found PFO. During the assessment of
arterial oxygen saturations, 17 patients experienced a de-
saturation of at least 8% to value 90%, thereby meeting
the criteria for PED. The patients with PED were not
demographically distinct from those without PED. Of the
17 patients identified to have PED, 13 underwent PFO
closure, and 10 of these patients completed follow-up. The
drop in oxygen saturation during exercise 3 months after
closure improved by an average of 10.1  4.2% (p  0.001)
(Fig. 1). Similarly, NYHA functional class improved by a
median of 1.5 classes (interquartile range: 0.75 to 2.00, p 
0.008). The individual patient data are shown in Table 2.
Only 6 patients were referred for PFO evaluation primar-
ily due to arterial oxygen desaturation, and 4 of these
patients demonstrated PED when tested. Interestingly, 13
cases of PED were noted in patients with no documented
history of oxygen desaturation. Twenty-one patients in the
entire cohort underwent subsequent closure of their PFO:
13 who demonstrated PED, and 8 who did not. Two
patients elected to undergo surgical closure of their PFO,
and 19 underwent percutaneous closure. Of those receiving
percutaneous PFO closure, 16 were closed with the Helex
device (Gore Medical, Flagstaff, Arizona), 1 was closed with
the Starflex device (NMT Medical, Boston, Massachusetts),
1 was closed with the CardioSeal (NMT Medical, Boston,
Massachusetts), and 1 was closed with the Amplatzer
cribiform device (AGA Medical, Plymouth, Minnesota).
Five patients were noted to have minor residual shunting on
postprocedure echocardiographic examination (1 post-
Amplatzer cribiform device, and 4 post-Helex device). Of
these 5 patients, 3 had initially demonstrated PED, and 2 of
these patients had completed follow-up. The presence of a
residual shunt did not seem to impact on the efficacy of
Table 1. Clinical Demographic Data Stratified by the Presence of PED
Demographic Data
All Patients
(n  50)
PED
(n  17)
No PED
(n  33) p Value
Age (yrs) 45.8 17 52 19 43 16 0.08
Female 74 76.5 72.7 1.00
Septal anatomy 0.76
PFO only 66 70.6 63.6
PFO  ASA 34 29.4 36.4
COPD 16 17.7 15.2 1.00
OSA 4 5.9 3 1.00
Lung surgery 0 0 0
Pulmonary hypertension 2 0 3 1.00
Migraine headaches 30 23.5 33.3 0.53
Stroke/TIA 48 47.1 48.5 1.00
Values are mean SD or %.
ASA atrial septal aneurysm; COPD chronic obstructive pulmonary disease; OSAobstruc-
tive sleep apnea; PED  provoked exercise desaturation; PFO  patent foramen ovale; TIA 
transient ischemic attack.PFO closure in ameliorating PED.Discussion
This prospective, single-center study used standardized
methods to determine the prevalence of provoked exercise
desaturation in a diverse patient cohort referred for evalua-
tion of a newly recognized PFO. Although platypnea
orthodeoxia syndrome is considered a rare phenomenon
(3,4,6), we identified a relatively high proportion of patients
Figure 1. Arterial Oxygen Desaturation Before and After Patent Foramen
Ovale Closure
The magnitude of exercise-induced oxygen desaturation experienced by
each provoked exercise desaturation patient both before and after patent
foramen ovale closure.
Table 2. Individual Patient Data for PED Patients Undergoing
PFO Closure and Then Seen in Follow-Up
Patient
#
Desaturation
Pre-Closure
Desaturation
Post-Closure
p
Value
NYHA
Pre-Closure
NYHA
Post-Closure
p
Value
1 12 0 1 1
2 10 3 3 1
3 10 6 4 3
4 8 4 3 1
5 15 2 2 2
6 14 1 3 2
7 10 3 2 1
8 17 2 3 1
9 16 2 3 1
10 14 2 3 1
12.6 (3)* 2.5 (1.6)* 0.001 3 (2–3)† 1 (1–2)† 0.008
*Mean (SD); †median (interquartile range).
NYHA  New York Heart Association; PED  provoked exercise desaturation; PFO  patentforamen ovale.
G
t
r
2
m
t
e
s
s
d
t
h
p
r
s
a
s
P
d
o
c
p
C
p
e
(
p
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 5 , N O . 4 , 2 0 1 2 Devendra et al.
A P R I L 2 0 1 2 : 4 1 6 – 9 PFO, Exercise Desaturation, and Device Closure
419(33%) who met the criteria for PED. This proportion
should likely not be applied to the general population of
patients with PFO, because it represents a cohort that was
referred for cardiovascular evaluation and consideration of
PFO closure and therefore is more likely to feature symp-
tomatic PFO. The greater implication, however, is that
arterial desaturation through a PFO is a particularly chal-
lenging diagnosis that is likely underdiagnosed in the
general population (11). Given that there is no consensus
mechanism for right-to-left shunting at normal cardiac
pressures and that POS commonly presents without pos-
tural changes (6), there might be a substantial number of
patients who experience PED or platypnea-type physiology
that go undiagnosed due to the inability to meet traditional
criteria or the inadequacy of current testing.
Nonetheless, PFO closure leads to resolution of arterial
oxygen desaturation and significant improvement in func-
tional capacity in PED patients. Although assessment of
NYHA functional class is subjective and might be subject to
placebo effect, the improvement in arterial desaturation
seems to be a common phenomenon and not just limited to
a few patients. Prior studies have retrospectively examined
the effect of PFO closure in POS patients and have shown
dramatic improvements in standing oxygen saturation (12–14).
However, these investigations limited their cohort to pa-
tients experiencing postural orthodeoxia. Our inclusion of
patients with exertional desaturations might have selected a
less restricted cohort that might be more reflective of the
diverse presentations resulting from shunt through a PFO.
We were also able to demonstrate symptomatic improve-
ment with PFO closure in all patients with PED who
underwent closure. There was a significant improvement in
NYHA functional class after PFO closure by an average of
1.3  0.8 classes (p  0.001). This is consistent with the
uérin et al. (4) retrospective multicenter study performing
ranscatheter PFO closure in 78 patients with POS, which
eported NYHA functional class improvement from grade
.7  0.7 to 1  1 after PFO closure.
These findings are the first to validate the important
echanistic role that PFO plays in the pathophysiology of
he transient desaturation observed in patients during stair
xercise and suggest that PFO closure might be an effective
trategy for improving arterial desaturation and functional
tatus in patients with PED. Our employment of a stan-
ardized assessment of arterial desaturation (including pos-
ural changes and standardized exertion) is likely to have
elped us identify a larger group of patients with POS-type
hysiology than would have been recognized with a more
outine assessment. These findings suggest that right-to-left
hunting through a PFO is an underdiagnosed phenomenon
nd implies that patients with poor functional class might
uffer from unrecognized shunting and might benefit fromFO closure. Furthermore, our method of assessing arterial
esaturation is simple to implement and should become part
f the routine assessment of PFO patients, particularly
onsidering that there is no a priori way to determine which
atients will desaturate. Although the recent results of the
LOSURE-I trial (10) have cast doubt upon the field of
ercutaneous PFO closure, our findings along with the
stablished safety of percutaneous PFO closure in POS
3,4) emphasize the continued utility of intervention in a
roperly selected patient population.
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